Algis J. Vingrys
About
In The Last Decade
Algis J. Vingrys
241 papers receiving 6.7k citations
Peers
Comparison fields: 5 of 162
- Ophthalmology 3.6k
- Radiology, Nuclear Medicine and Imaging 2.2k
- Molecular Biology 2.2k
- Cognitive Neuroscience 1.2k
- Epidemiology 858
Countries citing papers authored by Algis J. Vingrys
This map shows the geographic impact of Algis J. Vingrys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Algis J. Vingrys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Algis J. Vingrys more than expected).
Fields of papers citing papers by Algis J. Vingrys
This network shows the impact of papers produced by Algis J. Vingrys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Algis J. Vingrys. The network helps show where Algis J. Vingrys may publish in the future.
Co-authorship network of co-authors of Algis J. Vingrys
This figure shows the co-authorship network connecting the top 25 collaborators of Algis J. Vingrys. A scholar is included among the top collaborators of Algis J. Vingrys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Algis J. Vingrys. Algis J. Vingrys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 15 | |
| 3 | Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study | 0 |
| 4 | Using an iPad to measure Visual Fields in Children. | 1 |
| 5 | Retinal vascular reactivity in a mouse model of Alzheimer’s disease. | 1 |
| 6 | 37 | |
| 7 | 33 | |
| 8 | Clinical validation of a tablet perimeter | 2 |
| 9 | Age-related changes in retinal structure and function in a mouse model of Alzheimer's disease | 1 |
| 10 | 15 | |
| 11 | Using an Ipad Device to Test the Visual Fields of Patients with Neuro-Ophthalmic Diseases | 1 |
| 12 | NOVEL NANOSECOND LASER TREATMENT TO PREVENT VISION LOSS FROM AGE-RELATED MACULAR DEGENERATION | 1 |
| 13 | Angiotensin Type-1 Receptor Inhibition Is Neuroprotective to Amacrine Cells in a Rat Model of Retinopathy of Prematurity | 13 |
| 14 | The Effect of Dietary Omega–3 Fatty Acid Manipulation on Intraocular Pressure and Retinal Function | 1 |
| 15 | Can HMG Co–A Reductase Inhibitors (Statins) Slow the Progression of AMD? | 2 |
| 16 | Rod photoreceptor dysfunction in diabetic rats is associated with decreased Na/K–ATPase activity. | 1 |
| 17 | Omega–3 Fatty Acid Diets Ameliorate Retinal Dysfunction In Diabetes. | 1 |
| 18 | Spatiotemporal properties of the frequency doubling effect | 4 |
| 19 | Visual deficits in migraine sufferers: What do the methods tell us? | 2 |
| 20 | COLOR PERIMETRY CAN BE MORE SENSITIVE THAN ACHROMATIC PERIMETRY | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.